UIMF:XETRA:XETRA-UBS(Lux)Fund Solutions – MSCI Europe UCITS ETF(hedged EUR)A-acc (EUR)

ETF | Others |

Last Closing

USD 16.708

Change

-0.03 (-0.20)%

Market Cap

N/A

Volume

1.37K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.28 (-0.61%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.45 (-0.48%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.09 (-0.38%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.19 (-1.45%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.01 (-0.23%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.19 (-0.83%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.05 (-0.44%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.19 (-0.32%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.01 (-0.05%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.25 (+0.21%)

USD 12.26B

ETFs Containing UIMF:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.85% 88% B+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.85% 89% A- 83% B
Trailing 12 Months  
Capital Gain 5.56% 75% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.56% 76% C+ 71% C-
Trailing 5 Years  
Capital Gain 75.89% 74% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 75.89% 74% C 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 10.74% 69% C- 68% D+
Dividend Return 10.74% 68% D+ 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.82% 58% F 66% D+
Risk Adjusted Return 99.31% 86% B+ 88% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike